Neoadjuvant chemotherapy combined with endocrine therapy for hormone receptor-positive breast cancer: A systematic review and meta-analysis

BACKGROUND: This study aimed to conduct a comparative analysis of the efficacy and safety of neoadjuvant chemotherapy combined with endocrine therapy against the backdrop of single neoadjuvant chemotherapy or endocrine therapy, specifically in the context of hormone receptor-positive (HR+) breast ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Hong-Fang, Shen, Jun, Xu, Bin, Shen, Jian-Guo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
5750
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659694/
https://www.ncbi.nlm.nih.gov/pubmed/37986364
http://dx.doi.org/10.1097/MD.0000000000035928

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659694/
https://www.ncbi.nlm.nih.gov/pubmed/37986364
http://dx.doi.org/10.1097/MD.0000000000035928

Ejemplares similares